An Animal Explant Model for the Study of Human Cutaneous Squamous Cell Carcinoma

被引:2
|
作者
Belkin, Daniel A. [1 ]
Chen, Jie [2 ]
Mo, Jonathan L. [2 ]
Rosoff, James S. [2 ]
Goldenberg, Sagit [2 ]
Poppas, Dix P. [2 ]
Krueger, James G. [3 ]
Herschman, Miriam [4 ]
Mitsui, Hiroshi [3 ]
Felsen, Diane [2 ]
Carucci, John A. [4 ]
机构
[1] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA
[2] Weill Cornell Med Coll, Dept Urol, Inst Pediat Urol, New York, NY USA
[3] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA
[4] NYU, Langone Med Ctr, Ronald O Perelman Dept Dermatol, New York, NY 10003 USA
来源
PLOS ONE | 2013年 / 8卷 / 10期
关键词
NF-KAPPA-B; TUMOR MICROENVIRONMENT; XENOGRAFT MODEL; NUDE RATS; CANCER; TRANSFORMATION; METASTASIS; APOPTOSIS; MIGRATION; INVASION;
D O I
10.1371/journal.pone.0076156
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We established a human tissue explant model to facilitate study of cutaneous squamous cell carcinoma. We accomplished this by implanting debulked SCC, from surgical discard, into nude rats. Human SCC remained viable and continued to proliferate for at least 4 weeks and showed evidence of neovascularization. At 4 weeks, SCC implants showed a trend toward increased PCNA positive cells compared to fresh SCC cells/mm(2) tissue) supporting continued proliferation throughout engraftment. Von Willebrand's Factor (VWF) positive cells were found within implants and likely represented rat vessel neovascularization. Human Langerhans' (Langerin+) cells, but no T cells (CD3+, CD8+, FoxP3+), macrophages (CD163), or NK cells (NKp46), were present in SCC implants at 4 weeks. These findings support the possibility that LCs fail to migrate from cutaneous SCC and thus contribute to lack of effective antitumor response. Our findings also provide a novel model system for further study of primary cutaneous SCC.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Complement System in Cutaneous Squamous Cell Carcinoma
    Riihila, Pilvi
    Nissinen, Liisa
    Knuutila, Jaakko
    Nezhad, Pegah Rahmati
    Viiklepp, Kristina
    Kahari, Veli-Matti
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (14)
  • [42] Epidemiology of advanced cutaneous squamous cell carcinoma
    Dessinioti, C.
    Pitoulias, M.
    Stratigos, A. J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (01) : 39 - 50
  • [43] Decreased TMEM40 expression is associated with malignant behavior of cutaneous squamous cell carcinoma and inhibits tumor progression
    Yu, Lei
    Liu, Jie
    Zhang, Tang-De
    Zheng, Xiu-Fen
    Luo, Dong-Lan
    Zhu, Wei-Liang
    Qiu, Xian-Wen
    Guo, Lin-Lang
    ONCOLOGY LETTERS, 2021, 22 (02)
  • [44] Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma
    Boutros, Andrea
    Cecchi, Federica
    Tanda, Enrica Teresa
    Croce, Elena
    Gili, Riccardo
    Arecco, Luca
    Spagnolo, Francesco
    Queirolo, Paola
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [45] Cutaneous squamous cell carcinoma of the head and neck
    Deutsch, Jochen
    Dippel, Edgar
    Delank, K. -Wolfgang
    LARYNGO-RHINO-OTOLOGIE, 2023, 102 (03) : 186 - 193
  • [46] Tumor xenograft animal models for esophageal squamous cell carcinoma
    Lee, Nikki P.
    Chan, Chung Man
    Tung, Lai Nar
    Wang, Hector K.
    Law, Simon
    JOURNAL OF BIOMEDICAL SCIENCE, 2018, 25
  • [47] Update of advanced cutaneous squamous cell carcinoma
    de Jong, E.
    Lammerts, M. U. P. A.
    Genders, R. E.
    Bouwes Bavinck, J. N.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 : 6 - 10
  • [48] RANKL triggers resistance to TRAIL-induced cell death in oral squamous cell carcinoma
    Ethiraj, Purushoth
    Sambandam, Yuvaraj
    Hathaway-Schrader, Jessica D.
    Haque, Azizul
    Novince, Chad M.
    Reddy, Sakamuri, V
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (02) : 1663 - 1673
  • [49] MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1
    Zhou, Jianda
    Liu, Rui
    Luo, Chengqun
    Zhou, Xiao
    Xia, Kun
    Chen, Xiang
    Zhou, Ming
    Zou, Qiong
    Cao, Peiguo
    Cao, Ke
    CANCER BIOLOGY & THERAPY, 2014, 15 (10) : 1340 - 1349
  • [50] Antitumor effects of recombinant human adenovirus-p53 against human cutaneous squamous cell carcinoma in mice
    Li, Yuanchao
    He, Wei
    Wang, Rupeng
    Yang, Libin
    Zhou, Chunli
    Zhang, Bin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (06) : 4159 - 4167